SR9009 (Stenabolic) (30ml)

SR9009, often referred to as “the exercise pill,” is a Rev-Erbα receptor agonist, which sets it apart from traditional SARMs. Rather than binding to androgen receptors, SR9009 directly influences circadian metabolism, fat oxidation, and endurance by modulating Rev-Erbα activity. This effect leads to increased endurance, reduced body fat, and improved glucose utilization.

A major attraction of SR9009 is its potential to improve endurance without the need for exercise. Animal studies have shown that administration of SR9009 increases mitochondrial activity in skeletal muscle, thereby increasing endurance capacity. In addition to these effects, SR9009 has been associated with reduced fat mass and improved insulin sensitivity, which may have benefits for those looking to improve their body composition or manage their weight.

Unlike many other compounds, SR9009 does not interfere with testosterone production, meaning it does not cause typical hormonal side effects like testosterone suppression or estrogenic effects. However, it is important to note that SR9009 has a short half-life, requiring frequent dosing to maintain its effects, which may be impractical for some users.

In terms of side effects, SR9009 is generally well tolerated, although some people may experience sleep disturbances due to its impact on the circadian cycle. Additionally, while animal studies have shown promising results, human research remains limited, and the long-term effects are not yet well understood.

*Side effects reported in studies:*

1. Increased endurance and exercise capacity
2. Improved fat metabolism and insulin sensitivity
3. Potential reduction in sleep disturbances
4. No suppression of testosterone production
5. Need for frequent dosing due to short half-life

*Rating:*

– Mass gain: 1/5
– Fat loss: 4/5
– Strength gain: 2/5
– Safety profile: 3.75/5

*Average: 2.69/5*